Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

7.95 (USD) • At close January 6, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operationele Activiteiten:
Nettowinst -95.842-97.54-91.373-92.996-93.017-76.726-65.327-57.492-60.445-65.56-55.979-64.933-47.428-43.401-30.717-25.766-23.873-18.943-18.424
Afschrijvingen & Amortisatie 7.19887.415.6167.5785.5433.7283.2142.9892.7862.7672.2362.4362.3311.4021.6240.8571.0240.937
Uitgestelde Inkomstenbelasting 000-54.0570.01900000000.8270001.75700
Aandelen Gebaseerde Vergoedingen 18.25316.52416.12716.08616.79211.8118.8147.6958.9075.6755.6324.3413.3635.3171.8211.1881.070.7691.265
Verandering in Werkkapitaal 46.715-10.264-36.451-11.27-4.462-10.121-24.404-0.601-7.765-9.537122.824-3.9597.29-0.275-3.36231.5540.280.617-1.617
Vorderingen 0.3040.736-1.04-6.422-0.203-0.814-0.3175.5723.777-8.086-1.265-5.3760.0160.0130.08530.043-30.190.060.082
Voorraden 000-1.3340.2030.8140.317-5.572-3.7778.086006.6442.141-2.9984.233000
Crediteuren -1.513-1.3421.168-0.3172.186-2.517-0.3390.6950.714-0.9861.344-3.5073.130.0712.051-0.222-0.055-0.5330.625
Overig Werkkapitaal 47.924-9.658-36.579-4.531-6.648-7.604-24.065-1.296-8.479-8.551121.48-0.452-2.5-2.5-2.5-2.530.5251.09-2.324
Overige Niet-Contante Posten -35.54934.19132.79652.5440.172.0263.8732.4361.7735.0132.1441.1570.4642.3750.101-0.0270.453-0.1660.022
Kasstroom uit Operationele Activiteiten -59.225-82.219-102.3-74.077-72.92-67.467-73.316-44.748-54.541-61.62377.388-61.158-33.048-33.653-30.7558.573-19.456-16.699-17.817
Investeringsactiviteiten:
Investeringen in Materiële Vaste Activa -1.562-4.182-6.653-2.417-0.827-3.968-5.34-7.979-8.563-16.475-4.342-4.464-9.706-6.212-19.416-4.591-0.826-0.634-0.684
Netto Overnames 000-0.07101.91500000-184.1670000-2.600
Aankoop van Beleggingen 00000000000-116.97-184.167000000
Verkoop/verval van Beleggingen 00000.4800061.54721.415147.64669.1910000000
Overige Investeringsactiviteiten -3-30-0.350.3980-0.165-0.361.24721.415147.646184.167-184.16700-0.904-2.60.5950
Kasstroom uit Investeringsactiviteiten -4.562-4.182-6.653-2.488-0.347-2.053-5.34-7.97952.9844.94143.304-52.243-193.873-6.212-19.416-4.591-3.426-0.039-0.684
Financieringsactiviteiten:
Schuldaflossingen -2.287-0.026-0.026-0.694-0.024-0.024-0.024-0.023-0.023-0.022-0.022-0.021-12.737-0.02-0.02-0.02-0.020.3825.981
Uitgifte van Gewone Aandelen 16.968261.54610.87378.093503.8111.946143.7112.362.692.106462.9011.642463.7252.1540000
Terugkoop van Gewone Aandelen 0000000000000000000
Uitgekeerde Dividenden 0000000000000000000
Overige Financieringsactiviteiten 1.7811.6023.053.263.7893.8111.9463.5682.362.692.1063.8171.642463.7252.15410.055229.74100.016
Kasstroom uit Financieringsactiviteiten 16.462263.12213.89780.65953.7653.7871.922147.2562.3372.6682.0843.796-11.095463.7052.13410.035229.7210.3825.997
Overige Informatie:
Effect van Wisselkoersveranderingen op Kas 0.403-0.118-0.2190.124-0.1150.181-0.002-0.30700000000000
Netto Kasstroomverandering -40.293176.603-95.2755.218-19.617-65.552-76.73694.2220.78-54.015222.776-109.605-238.016423.84-48.03714.017206.839-16.356-12.504
Kaspositie aan het Einde van de Periode 435.831476.124299.521394.796397.207416.824482.376559.112464.89464.11518.125295.349404.954642.97219.13267.167253.1546.31162.667